A special issue dedicated to the 2021 meeting of the French Society for Nanomedicine.
| dc.rights.license | open | en_US |
| hal.structure.identifier | Laboratoire de Chimie des Polymères Organiques [LCPO] | |
| hal.structure.identifier | Team 3 LCPO : Polymer Self-Assembly & Life Sciences | |
| dc.contributor.author | GARANGER, Elisabeth
IDREF: 089451740 | |
| hal.structure.identifier | Unité de Technologies Chimiques et Biologiques pour la Santé [UTCBS - UM 4 (UMR 8258 / U1267)] | |
| dc.contributor.author | MIGNET, Nathalie | |
| hal.structure.identifier | Université d'Orléans [UO] | |
| dc.contributor.author | PICHON, Chantal | |
| hal.structure.identifier | Institut de pharmacologie et de biologie structurale [IPBS] | |
| dc.contributor.author | ROLS, Marie-Pierre | |
| hal.structure.identifier | Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) [IAB] | |
| dc.contributor.author | SANCEY, Lucie | |
| dc.date.accessioned | 2023-05-29T15:50:23Z | |
| dc.date.available | 2023-05-29T15:50:23Z | |
| dc.date.issued | 2023-05-10 | |
| dc.identifier.issn | 1873-3476 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/182350 | |
| dc.description.abstractEn | The field of nanomedicine has reached a milestone since the approval of Patisiran, the first ever-approved siRNA drug designed to treat transthyretin (TTR) amyloidosis. The great success of Corminaty and Spikevax messenger RNA (mRNA)-based vaccines against COVID-19 has really brought to light how potent nanomedicine could be. Today, stakeholders are getting more confident in the benefits of nanomedicine for diagnosis, treatment, vaccination, and research related to different types of diseases. For the years to come, it is becoming clear that we need a multidisciplinary approach to achieve a rational design of nanomedicine. Impelling the meeting and discussions of academic and private actors from different disciplines is one of the goals of the French Society for Nanomedicine (SFNano). | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
| dc.subject.en | Nanomedicine | |
| dc.subject.en | Drug Delivery Systems | |
| dc.subject.en | mRNA-based vaccines | |
| dc.subject.en | siRNA drugs | |
| dc.title.en | A special issue dedicated to the 2021 meeting of the French Society for Nanomedicine. | |
| dc.title.alternative | Int J Pharm | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.ijpharm.2023.122928 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Sciences pharmaceutiques | en_US |
| dc.identifier.pubmed | 37030637 | en_US |
| bordeaux.journal | International Journal of Pharmaceutics | en_US |
| bordeaux.page | 122928 | en_US |
| bordeaux.volume | 638 | en_US |
| bordeaux.hal.laboratories | Laboratoire de Chimie des Polymères Organiques (LCPO) - UMR 5629 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | Bordeaux INP | en_US |
| bordeaux.institution | CNRS | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.import.source | pubmed | |
| hal.identifier | hal-04109167 | |
| hal.version | 1 | |
| hal.date.transferred | 2023-05-29T15:50:26Z | |
| hal.export | true | |
| workflow.import.source | pubmed | |
| dc.rights.cc | CC BY-NC-SA | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=International%20Journal%20of%20Pharmaceutics&rft.date=2023-05-10&rft.volume=638&rft.spage=122928&rft.epage=122928&rft.eissn=1873-3476&rft.issn=1873-3476&rft.au=GARANGER,%20Elisabeth&MIGNET,%20Nathalie&PICHON,%20Chantal&ROLS,%20Marie-Pierre&SANCEY,%20Lucie&rft.genre=article |
